Celldex Therapeutics CLDX
NASDAQ CLDX
$32.39 +0.75 (+2.37%)
As of: Sep 30, 2026 · 12:51 PM EDT

Celldex Therapeutics, Inc. (CLDX) Short term Debt (2010 - 2013)

Updated

Celldex Therapeutics' Short term Debt was $5.63 million in Q1 2013, up 6.3% from $5.29 million a year earlier and up 0.7% from the prior quarter.

Analysis

Celldex Therapeutics, Inc. (CLDX) Short term Debt (2010 - 2013) Analysis & Trends

At the end of FY2012, Short term Debt at Celldex Therapeutics came in at $5.59 million, down 8.9% from FY2011.

  • In earlier years, Short term Debt was $6.14 million in FY2011 (-50.6%) and $12.41 million in FY2010.
  • The Q1 2013 figure marks the highest quarterly Short term Debt since Q4 2011.
  • Compared with a year earlier, Short term Debt was higher in three of the last five quarters, with an average decline of 3.6%.
  • Per Business Quant data, CLDX's Short term Debt in the three quarters before Q1 2013 was $5.59 million (Q4 2012), $5.29 million (Q3 2012) and $5.29 million (Q2 2012).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 5.63 Mn
Dec 31, 2012 5.59 Mn
Sep 30, 2012 5.29 Mn
Jun 30, 2012 5.29 Mn
Mar 31, 2012 5.29 Mn
Dec 31, 2011 6.14 Mn
Sep 30, 2011 4.09 Mn
Jun 30, 2011 5.00 Mn
Dec 31, 2010 12.41 Mn
API Access

Celldex Therapeutics, Inc. Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=CLDX&period=max&api_key=YOUR_API_KEY